Before visiting, please review our current visitor policies and COVID-19 information.
Methodist in the Media
KETV: Methodist Offering Unique Lung Cancer Clinical TrialPublished: Feb. 27, 2015
Lung cancer accounts for about 27% of all cancer deaths and is by far the leading cause of cancer death among both men and women according to the American Cancer Society.
A one of a kind clinical trial here in Omaha at Methodist Estabrook Cancer Center is exploring new treatment options for Stage 4 lung cancer patients.
Dr. Robert Langdon, Nebraska Cancer Specialists, spoke with KETV reporter Jobeth Devera about the clinical trial available at Methodist Estabrook Cancer Center and only 14 other sites in the U.S.